Big Data—a new player in the Healthcare Industry
April 2, 2015 |
Big Data is an exciting by-product of the information technology revolution and offers new ways of understanding customers.
Our previous blog explored the rise of Big Data and its importance to the market research industry. In this blog we investigate some of the ways in which big pharma have used big data and consider the specific implications for us, the healthcare market research industry.
Big data is exciting to healthcare because the integration of data sources, combined with the tremendous volume of data now available, affords pharma the chance to gain fresh insights into patient behavior and HCP decision-making, as well as make improvements to overall health system planning. Major pharma companies, such as Astra Zeneca and GSK, have been quick to embrace Big Data to gain additional market understanding. For example, Astra Zeneca recently partnered with a data analytics company, Healthcore, which analyses insurance claims. By combining large amounts of medical records with insurance claim data, AZ was able to establish the relationship between treatment effectiveness and cost of care. This helps the company to identify more effective and affordable treatment for patients. This level of analytics, which gives pharmaceutical companies a means of developing more effective pricing strategies, is one that traditional market research agencies are unlikely to be equipped to offer.
GSK applied Big Data analysis in order to identify target customers. By working with data analytics company Occam, GSK aimed to “identify people who are mentioning a particular brand of ours but also track everything else they are talking about in the public domain to build a customer profile”, said James Parker, GSK’s CRM consultant. In this example, Big Data could realise real-time monitoring and reporting, in a way which traditional market research agencies cannot.
Consequently, we as market researchers must face the question: With Big Data analytics on the increase, will primary market research become redundant?
We would like to think not. There are two skills required by both researchers conducting traditional primary market research and Big Data research. The first is an in-depth knowledge of the industry. This arms researchers with the ability to design the best solution to answer the business question. Secondly, researchers require the ability to analyze the findings and provide actionable recommendations which help companies increase their profitability and sustainability.
However, there are distinct differences between the two types of research in terms of approach and analysis. One characteristic of current Big Data research is that it is largely retrospective and mainly uses existing data. Sometimes the volume of data means that it can be used as a predictor of future behaviour, but this is open to misinterpretation. Big Data analysis sometimes gives ambiguous findings because of the limited context around the business question being addressed. Overall, Big Data is useful for making sense of the big picture and identifying overall trends and patterns but sometimes it can’t be relied upon to answer business questions at a more granular level.
Primary market research takes a more structured approach. Data collection and analysis are controlled, meaning the findings should directly answer the research objective and address the business question. It is very valuable when you want to gather in-depth insights from specific types of audiences.
So what does the future hold for the healthcare market research industry? Well we think ideally we should be working in partnership to deliver an integrated solution. Primary market research will still be required to fill the gaps in understanding which Big Data is unable to provide. And primary market research agencies, should explore the possibility of partnering with Big Data analytics agencies, or even developing in-house analytics team, in order to provide a one-stop market research service for clients.
Research Partnership is one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we use our expertise and experience to deliver intelligent, tailor-made solutions. We provide strategic recommendations that go beyond research, helping our clients to answer their fundamental business challenges. Find out more here: http://bit.ly/1F7rEiF
This content was provided by Research Partnership
Company Details
Latest Content from Research Partnership
Will gene therapies finally be commercially viable to pharma?
Our latest Free Thinking white paper explores the science behind the idea of gene therapy and takes a look at some of the core challenges medical researchers have faced when...
Wargaming in HCV
The challenge:Our client had a product ready for launch in the HCV landscape. A number of new competitor products were expected to alter the market dynamics. Given the stage of...
Living with Lupus: Breaking the Silence
Published in eyeforpharma July 2017 by Mariel Metcalfe
Demystifying human-centred design: the application of iterative, human-centric approaches in global health market research
One of the biggest buzz topics in the global health community over the last couple of years has been human-centred design, also referred to as behaviour-centred design. In this blog...
In the news: What will the UK’s recent general election result and ongoing Brexit negotiations mean for DfID funding for global health?
The UK’s Department for International Development (DfID) was established in 1997 with a mandate to tackle world poverty. Since its inception, it has played a major role in the global...
EphMRA 2017 round up
We were delighted to present, exhibit and sponsor this year’s EphMRA Annual Conference in Amsterdam, Netherlands.
Taking a hybrid qualitative-quantitative approach to research
Directors Phil Rosenberg and Chris Gaj discuss ways to achieve qualitative insights with quantitative precision and the benefits of a hybrid approach.Watch the video: https://www.researchpartnership.com/news/2017/06/video-taking-a-hybrid-qualitative-quantitative-appr...
20th anniversary celebrations
We recently celebrated our 20th year anniversary with parties for our employees across the globe.Find out more and view the photos https://www.researchpartnership.com/news/2017/06/20th-anniversary-party-photos/
Pharma CI Asia Conference & Exhibition 2017
13-14 July 2017, Singapore
Director Richard Head is joint winner of the 2017 EphMRA President’s Award
We are delighted to announce that Research Partnership’s Richard Head is joint winner of the 2017 EphMRA President's Award for his contribution to pharmaceutical market research